These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 8783779

  • 1. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
    Larochelle P.
    Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
    [Abstract] [Full Text] [Related]

  • 2. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R, Castellote E, Ocón J, Wagner B.
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
    [Abstract] [Full Text] [Related]

  • 3. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG, Mateos FA, Ramos TH, Lavilla MP, Capitán MC, Gil A.
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [Abstract] [Full Text] [Related]

  • 4. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
    White WB, Koch B, Stimpel M.
    Am J Ther; 1997 Apr; 4(4):123-9. PubMed ID: 10423601
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG, Stimpel M.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of quinapril in the elderly hypertensive patient.
    Forette B, Koen R, Vicaut E.
    Am Heart J; 1992 May; 123(5):1426-32. PubMed ID: 1575170
    [Abstract] [Full Text] [Related]

  • 8. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y, Lefebvre J, Provencher P, Poirier L.
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive effect of low-dose hydrochlorothiazide alone or in combination with quinapril in black patients with mild to moderate hypertension.
    Radevski IV, Valtchanova ZP, Candy GP, Hlatswayo MN, Sareli P.
    J Clin Pharmacol; 2000 Jul; 40(7):713-21. PubMed ID: 10883412
    [Abstract] [Full Text] [Related]

  • 10. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA, Chang SM, Chou TC.
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [Abstract] [Full Text] [Related]

  • 11. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
    Miller MA, Texter M, Gmerek A, Robbins J, Shurzinske L, Canter D.
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension.
    Taylor SH.
    Angiology; 1989 Apr; 40(4 Pt 2):382-8. PubMed ID: 2539763
    [Abstract] [Full Text] [Related]

  • 13. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH.
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
    Frishman WH, Greenberg S.
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
    [Abstract] [Full Text] [Related]

  • 15. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P, Haynes B, Maron N, Dugas S.
    Clin Ther; 1994 Oct; 16(5):838-53. PubMed ID: 7859244
    [Abstract] [Full Text] [Related]

  • 16. Quinapril for treatment of hypertension in Turkey: dose titration and diuretic combination treatment strategies.
    Yener G, Aran S, Bahceci M, Ozdemir K, Gultekin F, Lowe W.
    Clin Drug Investig; 2007 Oct; 27(9):613-22. PubMed ID: 17705570
    [Abstract] [Full Text] [Related]

  • 17. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E, Brusca A, Caponnetto S, Condorelli M, Corea L, Dal Palù C, Fogari R, Mameli P, Mancia G, Neri Serneri GG.
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
    Stimpel M, Koch B, Oparil S.
    Cardiology; 1998 May; 89(4):271-6. PubMed ID: 9643274
    [Abstract] [Full Text] [Related]

  • 19. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH, Estrella ME, Muñoz M.
    Clin Ther; 1992 May; 14(4):527-36. PubMed ID: 1525787
    [Abstract] [Full Text] [Related]

  • 20. Use of quinapril in the elderly patient.
    Schnaper HW.
    Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.